Sign in

CIK 0001048477

  • Large accelerated filer

BIOMARIN PHARMACEUTICAL INC

Sign in to watch
Ticker
BMRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680397820
Phone
+1 415-506-6700
Business address
105 DIGITAL DRIVE, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,466,459
in 2 filings

Net −$1,466,459. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-03-15 FUCHS HENRY J President, Worldwide R&D Grant or award · Stock Option (Right to buy Common Stock) +37,710 37,710
2021-03-15 Ajer Jeffrey Robert EVP, Chief Commercial Officer Grant or award +10,720 72,001
2021-03-15 Ajer Jeffrey Robert EVP, Chief Commercial Officer Shares withheld for taxes −5,273 $78.39 $413K 66,728
2021-03-15 Ajer Jeffrey Robert EVP, Chief Commercial Officer Grant or award · Stock Option (Right to buy Common Stock) +26,400 26,400
2021-03-15 BIENAIME JEAN JACQUES Chief Executive Officer Grant or award +41,350 337,002
2021-03-15 BIENAIME JEAN JACQUES Chief Executive Officer Shares withheld for taxes −23,426 $78.39 $1.8M 313,576
2021-03-15 BIENAIME JEAN JACQUES Chief Executive Officer Grant or award · Stock Option (Right to buy Common Stock) +101,820 101,820
2021-03-15 Acosta Andrea GVP, Chief Accounting Officer Grant or award +4,290 19,068
2021-03-15 Acosta Andrea GVP, Chief Accounting Officer Shares withheld for taxes −553 $78.39 $43K 18,515
2021-03-15 Acosta Andrea GVP, Chief Accounting Officer Grant or award · Stock Option (Right to buy Common Stock) +5,280 5,280
2021-03-12 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion +7,000 $26.49 $185K 302,652
2021-03-12 BIENAIME JEAN JACQUES Chief Executive Officer Sale −7,000 $77.10 $540K 295,652
2021-03-12 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to buy Common Stock) −7,000 78,513
2021-03-11 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion +7,000 $26.49 $185K 302,652
2021-03-11 BIENAIME JEAN JACQUES Chief Executive Officer Sale −7,000 $77.68 $544K 295,652
2021-03-11 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to buy Common Stock) −7,000 85,513
2021-03-05 GREY MICHAEL G Director Exercise or conversion +5,000 $26.49 $132K 47,840
2021-03-05 GREY MICHAEL G Director Sale −5,000 $76.28 $381K 42,840
2021-03-05 GREY MICHAEL G Director Exercise or conversion · Stock Option (Right to buy Common Stock) −5,000 0
2021-03-04 BIENAIME JEAN JACQUES Chief Executive Officer Other acquisition +100 $77.94 $8K 295,652

Page 32 of 36 · 707 trades